Amyris Inc. [NASDAQ: AMRS] closed the trading session at $3.93 on 09/12/22. The day’s price range saw the stock hit a low of $3.61, while the highest price level was $4.05. The company report on September 7, 2022 that AMYRIS TO PARTICIPATE AT SEPTEMBER INVESTOR CONFERENCES.
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that management will participate in fireside chats moderated by equity research analysts, and provide updates, at two upcoming investor conferences:.
H.C. Wainwright 24th Annual Global Investment Conference, Monday, September 12 at 7:00 AM ET (virtual).
The stocks have a year to date performance of -27.36 percent and weekly performance of 43.96 percent. The stock has been moved at -3.91 percent over the last six months. The stock has performed 24.76 percent around the most recent 30 days and changed 91.71 percent over the most recent 3-months.
If compared to the average trading volume of 6.67M shares, AMRS reached to a volume of 7852899 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Amyris Inc. [AMRS]:
ROTH Capital have made an estimate for Amyris Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 10, 2022. While these analysts kept the previous recommendation, JP Morgan raised their target price to Neutral. The new note on the price target was released on June 24, 2022, representing the official price target for Amyris Inc. stock. Previously, the target price had yet another raise to $2.50, while Piper Sandler analysts kept a Neutral rating on AMRS stock.
The Average True Range (ATR) for Amyris Inc. is set at 0.46, with the Price to Sales ratio for AMRS stock in the period of the last 12 months amounting to 5.13.
AMRS stock trade performance evaluation
Amyris Inc. [AMRS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 43.96. With this latest performance, AMRS shares gained by 24.76% in over the last four-week period, additionally sinking by -3.91% over the last 6 months – not to mention a drop of -70.45% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMRS stock in for the last two-week period is set at 66.82, with the RSI for the last a single of trading hit 72.02, and the three-weeks RSI is set at 63.64 for Amyris Inc. [AMRS]. The present Moving Average for the last 50 days of trading for this stock 2.55, while it was recorded at 3.45 for the last single week of trading, and 3.69 for the last 200 days.
Amyris Inc. [AMRS]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Amyris Inc. [AMRS] shares currently have an operating margin of -48.31 and a Gross Margin at +51.77. Amyris Inc.’s Net Margin is presently recorded at -79.12.
Return on Equity for this stock declined to -679.38, with Return on Assets sitting at -45.95.
Amyris Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.10 and a Current Ratio set at 1.70.
Amyris Inc. [AMRS]: Insider Ownership positions
There are presently around $547 million, or 46.40% of AMRS stock, in the hands of institutional investors. The top three institutional holders of AMRS stocks are: FARALLON CAPITAL MANAGEMENT LLC with ownership of 21,209,882, which is approximately 25.269% of the company’s market cap and around 0.60% of the total institutional ownership; VANGUARD GROUP INC, holding 19,080,507 shares of the stock with an approximate value of $74.99 million in AMRS stocks shares; and BLACKROCK INC., currently with $52.62 million in AMRS stock with ownership of nearly -38.21% of the company’s market capitalization.
Positions in Amyris Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 100 institutional holders increased their position in Amyris Inc. [NASDAQ:AMRS] by around 19,187,882 shares. Additionally, 109 investors decreased positions by around 27,868,588 shares, while 45 investors held positions by with 92,201,884 shares. The mentioned changes placed institutional holdings at 139,258,354 shares, according to the latest SEC report filing. AMRS stock had 28 new institutional investments in for a total of 4,562,944 shares, while 37 institutional investors sold positions of 7,424,764 shares during the same period.